{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-034334","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2026-07-23T12:05:26+00:00","discovered_at":"2026-07-23T12:10:02.392231+00:00","generated_at":"2026-07-23T12:10:23.904855+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bone Biologics raises $3M, extends runway to Q2 2027, advances NB1 study","bullets":["Completed $3.0M private placement with healthcare-focused institutional investor; warrants could add up to $6.0M if exercised.","Operating runway extended through Q2 2027; proceeds to fund clinical trials, patent portfolio, and working capital.","NB1 first-in-human pilot study enrollment expected to complete by year-end 2026; interim updates possible.","Validated shelf life of rhNELL-1 protein extended to 29 months, up from 24 months in December 2025.","CEO Jeff Frelick highlights progress on 2026 priorities: clinical execution, product stability, IP protection, capital visibility."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-034334","json":"https://secwatch.observer/filing/0001493152-26-034334.json","markdown":"https://secwatch.observer/filing/0001493152-26-034334.md","text":"https://secwatch.observer/filing/0001493152-26-034334.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226034334/0001493152-26-034334-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226034334/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-23T12:10:23.904855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}